Metformin for the treatment of polycystic ovary syndrome (PCOS)

Satin S. Patel, Victor E. Beshay, Bruce R. Carr

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Because of the high prevalence of insulin resistance, there is a growing interest in the application of insulin sensitizing agents in patients with polycystic ovary syndrome (PCOS). Metformin is the most widely prescribed insulin sensitizing agent in patients with PCOS. In this chapter, we address the importance of lifestyle modification as the initial intervention in patients with PCOS. Furthermore, we discuss the efficacy of metformin compared to low-dose estrogen/progestin oral contraceptives in restoring menstrual cyclicity, reducing androgen excess, and protecting against uterine malignancies. Additionally, the role of metformin in PCOS patients with infertility is addressed.

Original languageEnglish (US)
Title of host publicationBiennial Review of Infertility: Volume 1
PublisherHumana Press
Pages21-28
Number of pages8
ISBN (Print)9781603273916
DOIs
StatePublished - 2009

Fingerprint

Polycystic Ovary Syndrome
Metformin
Proxy
Insulin
Periodicity
Progestins
Therapeutics
Oral Contraceptives
Infertility
Androgens
Insulin Resistance
Life Style
Estrogens
Neoplasms

Keywords

  • Androgen
  • Anovulation
  • Hyperinsulinemia
  • Metformin
  • PCOS
  • Polycystic ovary syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Patel, S. S., Beshay, V. E., & Carr, B. R. (2009). Metformin for the treatment of polycystic ovary syndrome (PCOS). In Biennial Review of Infertility: Volume 1 (pp. 21-28). Humana Press. https://doi.org/10.1007/978-1-60327-392-3_2

Metformin for the treatment of polycystic ovary syndrome (PCOS). / Patel, Satin S.; Beshay, Victor E.; Carr, Bruce R.

Biennial Review of Infertility: Volume 1. Humana Press, 2009. p. 21-28.

Research output: Chapter in Book/Report/Conference proceedingChapter

Patel, SS, Beshay, VE & Carr, BR 2009, Metformin for the treatment of polycystic ovary syndrome (PCOS). in Biennial Review of Infertility: Volume 1. Humana Press, pp. 21-28. https://doi.org/10.1007/978-1-60327-392-3_2
Patel SS, Beshay VE, Carr BR. Metformin for the treatment of polycystic ovary syndrome (PCOS). In Biennial Review of Infertility: Volume 1. Humana Press. 2009. p. 21-28 https://doi.org/10.1007/978-1-60327-392-3_2
Patel, Satin S. ; Beshay, Victor E. ; Carr, Bruce R. / Metformin for the treatment of polycystic ovary syndrome (PCOS). Biennial Review of Infertility: Volume 1. Humana Press, 2009. pp. 21-28
@inbook{b76c2fed9e5d46c392e1193009b466d7,
title = "Metformin for the treatment of polycystic ovary syndrome (PCOS)",
abstract = "Because of the high prevalence of insulin resistance, there is a growing interest in the application of insulin sensitizing agents in patients with polycystic ovary syndrome (PCOS). Metformin is the most widely prescribed insulin sensitizing agent in patients with PCOS. In this chapter, we address the importance of lifestyle modification as the initial intervention in patients with PCOS. Furthermore, we discuss the efficacy of metformin compared to low-dose estrogen/progestin oral contraceptives in restoring menstrual cyclicity, reducing androgen excess, and protecting against uterine malignancies. Additionally, the role of metformin in PCOS patients with infertility is addressed.",
keywords = "Androgen, Anovulation, Hyperinsulinemia, Metformin, PCOS, Polycystic ovary syndrome",
author = "Patel, {Satin S.} and Beshay, {Victor E.} and Carr, {Bruce R.}",
year = "2009",
doi = "10.1007/978-1-60327-392-3_2",
language = "English (US)",
isbn = "9781603273916",
pages = "21--28",
booktitle = "Biennial Review of Infertility: Volume 1",
publisher = "Humana Press",

}

TY - CHAP

T1 - Metformin for the treatment of polycystic ovary syndrome (PCOS)

AU - Patel, Satin S.

AU - Beshay, Victor E.

AU - Carr, Bruce R.

PY - 2009

Y1 - 2009

N2 - Because of the high prevalence of insulin resistance, there is a growing interest in the application of insulin sensitizing agents in patients with polycystic ovary syndrome (PCOS). Metformin is the most widely prescribed insulin sensitizing agent in patients with PCOS. In this chapter, we address the importance of lifestyle modification as the initial intervention in patients with PCOS. Furthermore, we discuss the efficacy of metformin compared to low-dose estrogen/progestin oral contraceptives in restoring menstrual cyclicity, reducing androgen excess, and protecting against uterine malignancies. Additionally, the role of metformin in PCOS patients with infertility is addressed.

AB - Because of the high prevalence of insulin resistance, there is a growing interest in the application of insulin sensitizing agents in patients with polycystic ovary syndrome (PCOS). Metformin is the most widely prescribed insulin sensitizing agent in patients with PCOS. In this chapter, we address the importance of lifestyle modification as the initial intervention in patients with PCOS. Furthermore, we discuss the efficacy of metformin compared to low-dose estrogen/progestin oral contraceptives in restoring menstrual cyclicity, reducing androgen excess, and protecting against uterine malignancies. Additionally, the role of metformin in PCOS patients with infertility is addressed.

KW - Androgen

KW - Anovulation

KW - Hyperinsulinemia

KW - Metformin

KW - PCOS

KW - Polycystic ovary syndrome

UR - http://www.scopus.com/inward/record.url?scp=84885811188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885811188&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-392-3_2

DO - 10.1007/978-1-60327-392-3_2

M3 - Chapter

AN - SCOPUS:84885811188

SN - 9781603273916

SP - 21

EP - 28

BT - Biennial Review of Infertility: Volume 1

PB - Humana Press

ER -